Description
Product Description
Incadronate Disodium is a synthetic bisphosphonate designed for laboratory research into skeletal biology, particularly osteoclast-mediated bone resorption. Its nitrogen-containing structure confers high potency, allowing it to inhibit farnesyl pyrophosphate synthase (FPPS) in the mevalonate pathway, thereby preventing protein prenylation necessary for osteoclast function and survival.
In preclinical research, Incadronate Disodium is used to investigate molecular pathways of bone remodeling, including apoptosis induction in osteoclasts, modulation of cytokine signaling, and the impact on mineralized matrix turnover. In vitro assays show dose-dependent inhibition of osteoclast differentiation and activity, while ex vivo models using bone slices demonstrate decreased resorption pit formation.
Researchers also employ Incadronate Disodium to study interactions with other therapeutic agents, explore combination strategies, and evaluate anti-resorptive mechanisms relevant to osteoporosis, metastatic bone disease, and other bone-related pathologies. Its high water solubility, chemical stability, and consistent purity make it suitable for mechanistic studies, high-throughput screening, and reproducible preclinical experiments.
Beyond osteoclast inhibition, Incadronate Disodium has been investigated for its potential immunomodulatory effects in bone microenvironments and for its capacity to influence cytokine release from bone marrow-derived cells. These multifaceted activities make it a versatile tool in the study of skeletal biology and pharmacology.
Product Specifications
| Item | Details |
|---|---|
| Product Name | Incadronate Disodium |
| CAS Number | 138330-18-4 |
| Synonyms | Sodium Incadronate; Incadronate Na2 |
| Molecular Formula | C6H10NNa2O7P2 |
| Molecular Weight | 305.09 g/mol |
| Purity | ≥99% |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water |
| Storage Temperature | 2–8 °C |
| Category | Bisphosphonate |
| Applications | Bone research, osteoclast inhibition studies, osteoporosis models, anti-resorptive mechanism research |
| Formulation | Suitable for in vitro, ex vivo, and preclinical studies |
| Stability | Stable under recommended storage conditions |
| Shelf Life | 24 months |
| Supplier Type | Research chemical supplier |
| Intended Use | For laboratory research use only |
Mechanism of Action
Incadronate Disodium primarily inhibits osteoclast-mediated bone resorption through the following mechanisms:
Farnesyl Pyrophosphate Synthase Inhibition
The nitrogen-containing bisphosphonate binds to FPPS in the mevalonate pathway, blocking the synthesis of isoprenoid lipids. This prevents prenylation of small GTP-binding proteins (e.g., Ras, Rho, Rac) essential for osteoclast function.Osteoclast Apoptosis Induction
Disruption of protein prenylation leads to cytoskeletal abnormalities, loss of resorptive activity, and apoptosis of mature osteoclasts, reducing bone resorption.Bone Matrix Binding
Incadronate exhibits high affinity for hydroxyapatite in bone, preferentially localizing to resorption surfaces and ensuring targeted activity where osteoclasts are active.Cytokine Modulation
Research indicates that Incadronate can modulate RANKL and OPG signaling, influencing osteoclast differentiation and survival indirectly via paracrine signaling from osteoblasts or bone marrow cells.Synergistic Research Applications
Incadronate is commonly used in combination with other bone-targeting agents or immunomodulatory compounds to study synergistic effects on bone turnover and osteoclast-mediated pathology.
Side Effects
In laboratory research, side effects relate primarily to its cytotoxic effects on osteoclasts:
Dose-dependent apoptosis in osteoclast cultures.
Reduced resorption pit formation in bone slice assays.
Potential cytotoxicity in non-target cells at very high concentrations.
Proper handling with PPE and adherence to institutional biosafety guidelines is required.
The compound is for laboratory research only and should not be administered to humans or animals.
Keywords
Incadronate Disodium, bisphosphonate, osteoclast inhibitor, bone resorption, osteoporosis research, anti-resorptive agent, skeletal biology, high-purity research compound, laboratory chemical, preclinical bone studies.
Shipping Guarantee
All Incadronate Disodium shipments are handled using validated cold-chain logistics to preserve compound integrity. Each package is sealed in moisture-proof containers with secondary protective wrapping and continuous temperature monitoring. Products are shipped via express international couriers with full tracking and insurance coverage.
Trade Assurance
We Incadronate Disodium ensure product authenticity, verified ≥99% purity, and compliance with analytical standards (HPLC, MS, NMR). Each batch is supplied with a Certificate of Analysis (CoA). Our trade assurance policy guarantees replacement or refund for any deviation from listed specifications.
Payment Support
We Incadronate Disodium provide flexible and secure global payment options to support international research transactions. Accepted payment methods include PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and cryptocurrencies (USDT, Bitcoin, Ethereum). All transactions are protected by industry-standard encryption and verified payment gateways to ensure confidentiality and fund security.
Disclaimer
All Incadronate Disodium products listed are intended for laboratory research use only and not for human or veterinary use. They are not drugs, medical devices, or diagnostics and should not be administered to humans or animals. Researchers must handle all materials in accordance with institutional biosafety and chemical safety guidelines. The information provided is for scientific reference only and does not imply therapeutic efficacy, safety, or regulatory approval.



Reviews
There are no reviews yet.